Lincoln Pharmaceuticals Ltd (LPL) on Wednesday launched the capsule version of Tinnex as a cure for tinnitus (ringing sensation in the ear), as the next step of the launch of this drug.
The success rate of cure of patients using Tinnex is 61 per cent, an official said here.
The Ahmedabad-based listed company, having a turnover of Rs 130 crore in 2010-11, had developed Tinnex following an agreement with Phafag AG, Switzerland, for its Caroverine molecule, Mr Mahendra G. Patel, Managing Director, said.